The treatment of spinal metastases
- PMID: 21311714
- PMCID: PMC3036978
- DOI: 10.3238/arztebl.2011.0071
The treatment of spinal metastases
Abstract
Background: The rising life expectancy of cancer patients has led to a greater need for treatment of spinal metastases. Interdisciplinary collaboration is important so that each patient's treatment can be properly tailored to the overall prognosis. The main factors to be considered are the histology of the primary tumor, potential spinal instability, and compression of neural structures.
Methods: We discuss the treatment options for spinal metastases on the basis of a selective literature review and our own extensive experience in an interdisciplinary tumor center.
Results: For spinal canal compression or impending spinal instability, the treatment of choice is decompression and stabilization, by either a dorsal approach (lumbar and thoracic spine) or a ventral approach (cervical spine). Radical ventral tumor resection is indicated only for solitary metastases in patients with a favorable long-range prognosis. If the tumor is radiosensitive, radiotherapy is given either as adjuvant treatment after surgery or as the primary treatment for multiple spinal metastases in the absence of an acute neurological deficit. Various fractionation schemes with different total radiation doses are used. Bisphosphonate treatment is an integral component of the overall treatment strategy.
Conclusion: The treatment of spinal metastases requires interdisciplinary collaboration and must be tailored to each patient's overall prognosis.
Figures
Comment in
-
Correspondence (letter to the editor): Computed tomography was omitted.Dtsch Arztebl Int. 2011 May;108(20):356. doi: 10.3238/arztebl.2011.0356a. Epub 2011 May 20. Dtsch Arztebl Int. 2011. PMID: 21655465 Free PMC article. No abstract available.
-
Correspondence (letter to the editor): Incidence of jaw necrosis is markedly higher.Dtsch Arztebl Int. 2011 May;108(20):356. doi: 10.3238/arztebl.2011.0356b. Epub 2011 May 20. Dtsch Arztebl Int. 2011. PMID: 21655466 Free PMC article. No abstract available.
-
Correspondence (letter to the editor): Nuclear medicine offers therapeutic options for multiple bone metastases.Dtsch Arztebl Int. 2011 May;108(20):357. doi: 10.3238/arztebl.2011.0357a. Epub 2011 May 20. Dtsch Arztebl Int. 2011. PMID: 21655467 Free PMC article. No abstract available.
-
Correspondence (letter to the editor): Additional remarks.Dtsch Arztebl Int. 2011 May;108(20):357. doi: 10.3238/arztebl.2011.0357b. Epub 2011 May 20. Dtsch Arztebl Int. 2011. PMID: 21655468 Free PMC article. No abstract available.
References
-
- Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin. 2000;50:7–33. - PubMed
-
- Rougraff BT, Kneisl JS, Simon MA. Skeletal metastases of unknown origin: A prospective study of a diagnostic strategy. J Bone Joint Surg [Am] 1993;75:1276–1281. - PubMed
-
- Rades D, Fehlauer F, Veninga T, et al. Functional outcome and survival after radiotherapy of metastatic spinal cord compression in patients with cancer of unknown primary. Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):532–537. - PubMed
-
- Ulmar B, Huch K, Kocak T, Catalkaya S, Naumann U, Gerstner S, Reichel H. The prognostic influence of primary tumour and region of the affected spinal segment in 217 surgical patients with spinal metastases of different entities. Z Orthop Ihre Grenzgeb. 2007 Jan–Feb;145(1):31–38. - PubMed
-
- Tokuhashi Y, Matsuzaki H, Toriyama S, Kawano H, Ohsaka S. Scoring system for the preoperative evaluation of metastatic spine tumor prognosis. Spine. 1990;15(11):1110–1113. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
